Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification. (2019)
Attributed to:
Integrating innovative technologies for genotyping and phenotyping in stratified medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bju.14808
PubMed Identifier: 31077629
Publication URI: http://europepmc.org/abstract/MED/31077629
Type: Journal Article/Review
Volume: 124
Parent Publication: BJU international
Issue: 3
ISSN: 1464-4096